Viewing Study NCT00003293


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2025-12-27 @ 2:35 AM
Study NCT ID: NCT00003293
Status: COMPLETED
Last Update Posted: 2012-09-11
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1998-02
Start Date Type: None
Primary Completion Date: 2001-05
Primary Completion Date Type: ACTUAL
Completion Date: 2001-05
Completion Date Type: ACTUAL
First Submit Date: 1999-11-01
First Submit QC Date: None
Study First Post Date: 2004-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-09-10
Last Update Post Date: 2012-09-11
Last Update Post Date Type: ESTIMATED